Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
HEALTHEQUITY, INC. reported the fiscal year ending January 31, 2025 results: revenue $1.140 billion to $1.160 billion. Guidance reaffirmed.
- Period
- the fiscal year ending January 31, 2025
- Revenue
- $1.140 billion to $1.160 billion
- Guidance
- reaffirmed
- Result
- guidance update
Exact text from the filing
For the fiscal year ending January 31, 2025, the Company affirmed its previously provided outlook, which assumes an average annualized yield on HSA cash of approximately 3%, as follows: • Revenue in the range of $1.140 billion to $1.160 billion;
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
HEALTHEQUITY, INC. reported the fiscal year ended January 31, 2024 results: revenue $995 million to $1 billion, net income $49 million to $52 million, EPS $0.56 to $0.60. Guidance raised.
- Period
- the fiscal year ended January 31, 2024
- Revenue
- $995 million to $1 billion
- Net income
- $49 million to $52 million
- EPS
- $0.56 to $0.60
- Guidance
- raised
- Result
- guidance update
Exact text from the filing
For the fiscal year ended January 31, 2024, the Company revised its previously provided outlook as follows: • Revenue in the range of $995 million to $1 billion; • Net income in the range of $49 million to $52 million; • Net income per diluted share in the range of $0.56 to $0.60;
View on SEC.gov